MedTrace Logo

Efficacy and Safety of a Dietary Supplement on Hair Growth and Hair Health in Female With Acute Telogen Effluvium

NCT06545552 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2025-06-05

No results posted yet for this study

Summary

The study is aimed to assess the efficacy of a food supplement in reducing hair loss and accelerating the physiological growth in terms of elongation in female subjects showing acute telogen effluvium. Moreover, the efficacy of the product in increasing hair elasticity, thickness and brightness will be assess.

In order to reach this goal a randomized, double-blind, placebo controlled, parallel group (2 arms), clinical trial is carried out on 66 healthy female subjects aged between 18 and 52 years old, showing acute telogen effluvium will be enrolled.

Conditions

  • Telogen Effluvium
  • Healthy

Interventions

DIETARY_SUPPLEMENT

An oral formulation of green tea extract, bamboo shoot extract and selenium-enriched yeast

Hard shell capsule containing 280mg of the oral formulation

DIETARY_SUPPLEMENT

Placebo

Hard shell capsule containing maltodextrine

Sponsors & Collaborators

  • Complife Italia Srl

    collaborator INDUSTRY

  • Activ'inside

    lead INDUSTRY

Principal Investigators

  • Gloria Roveda, MD, PhD · Complife Italia srl Via Mons. Angelini, 21 27028 San Martino Siccomario (PV)

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
52 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-09-30
Primary Completion
2025-01-24
Completion
2025-01-24

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06545552 on ClinicalTrials.gov